Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (3y) (2018 - 2024)
Syndax Pharmaceuticals (SNDX) EBITDA Margin Growth (3y) (2018 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-133,040.00 |
| Sep 30, 2024 |
-49,668.00 |
| Jun 30, 2024 |
409,634.00 |
| Dec 31, 2021 |
516,328.00 |
| Sep 30, 2021 |
439,359.00 |
| Jun 30, 2021 |
-122,507.00 |
| Mar 31, 2021 |
-217,335.00 |
| Dec 31, 2020 |
-359,270.00 |
| Sep 30, 2020 |
-45,973.00 |
| Jun 30, 2020 |
-2,430.00 |
| Mar 31, 2020 |
26,442.00 |
| Dec 31, 2019 |
-8,537.00 |
| Sep 30, 2019 |
154,437.00 |
| Jun 30, 2019 |
-117,030.00 |
| Mar 31, 2019 |
-44,360.00 |
| Dec 31, 2018 |
-355,353.00 |
| Sep 30, 2018 |
-263,977.00 |
| Jun 30, 2018 |
3.18 Mn |
